@article{24009,
  author = {Poulter N and Makino H and Remuzzi G and Toto R and Coresh J and Heerspink H and Heerspink H and Dwyer J and Inker L and Levey A and Brenner B and De Z and Greene T and Wanner C and von E and Ihle B and van d and de J and Hou F and Parving H and Ito S and Lewis E and Blankestijn P and Gansevoort R and van Z and Perkovic V and Wetzels J and Floege J and Fervenza F and Katafuchi R and Li P and Tighiouart H and Simon A and Chan T and Lewis J and Lewis J and Locatelli F and Praga M and Schena F and Sevillano A and Kamper A and Maes B and Barret B and Leung C and Szeto C and Fitzner C and Pozzi C and Montagnino C and Xie D and Verde E and Gutierrez E and Imai E and Caravaca F and Kobayashi F and Moroni G and Becker G and Beck G and Appel G and Frisch G and van E and Maschio G and Montogrino G and Jehan I and Donadio J and Kusek J and Lachin J and Luño J and Abebe K and Chow K and Hunsicker L and del V and Carlo M and Goicoechea M and Chaturvedi N and Passerini P and Ruggenenti P and Zucchelli P and Kincaid-Smith P and Hilgers R and Estacio R and Rohde R and Schrier R and Rodby R and Perrone R and Klahr S and Andrulli S and Strandgaard S and Hannedouche T and Rauen T and Verdalles U and Keane W},
  title = {Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials},
  year = {2019},
  journal = {The Lancet Diabetes and Endocrinology},
  volume = {7},
  pages = {128 - 139},
  doi = {10.1016/S2213-8587(18)30314-0},
  language = {eng},
}